Both hypo- and hyperglycaemia are associated with increased fracture risk in Japanese people with type 2 diabetes: the Fukuoka Diabetes Registry.


Journal

Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858

Informations de publication

Date de publication:
05 2020
Historique:
accepted: 23 09 2019
pubmed: 27 9 2019
medline: 8 9 2021
entrez: 27 9 2019
Statut: ppublish

Résumé

The impact of glycaemic control on fracture risk is controversial, which may be due to the possible presence of hypoglycaemia. The aim of this study was to separately investigate the impacts of severe hypoglycaemia and poor glycaemic control on fracture risk in people with type 2 diabetes. Overall, 4706 Japanese participants (2755 men and 1951 postmenopausal women) with type 2 diabetes (mean age 66 years) were followed prospectively (a median of 5.3 years; follow-up rate, 97.6%), and were stratified by severe hypoglycaemia status and glycaemic control. The primary outcome was fractures at any anatomic site. Fractures occurred in 662 participants (249 men and 413 women). The age- and sex-adjusted incidence rates (expressed per 1000 person-years) were: 71.2 (multiple episodes of severe hypoglycaemia), 43.1 (one episode), 25.2 [HbA Both severe hypoglycaemia and poor glycaemic control were significantly related to an increased risk of fracture in people with type 2 diabetes, although severe hypoglycaemia conferred a stronger risk.

Identifiants

pubmed: 31556147
doi: 10.1111/dme.14142
doi:

Substances chimiques

Hypoglycemic Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

838-847

Subventions

Organisme : Japan Society for the Promotion of Science KAKENHI
Pays : International
Organisme : Ministry of Education, Culture, Sports, Science and Technology of Japan
ID : 23249037
Pays : International
Organisme : Ministry of Education, Culture, Sports, Science and Technology of Japan
ID : 23659353
Pays : International
Organisme : Ministry of Education, Culture, Sports, Science and Technology of Japan
ID : 16K00861
Pays : International
Organisme : Junior Scientist Development Grant supported by the Japan Diabetes Society
Pays : International
Organisme : Lilly Research Grant Program for Bone & Mineral Research
Pays : International

Informations de copyright

© 2019 Diabetes UK.

Références

Compston J. Type 2 diabetes mellitus and bone. J Intern Med 2018; 283: 140-153.
Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999; 353: 878-882.
Yau RK, Strotmeyer ES, Resnick HE, Sellmeyer DE, Feingold KR, Cauley JA et al. Diabetes and risk of hospitalized fall injury among older adults. Diabetes Care 2013; 36: 3985-3991.
Garnero P, Borel O, Gineyts E, Duboeuf F, Solberg H, Bouxsein ML et al. Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone 2006; 38: 300-309.
Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 2010; 21: 195-214.
Okazaki K, Yamaguchi T, Tanaka K, Notsu M, Ogawa N, Yano S et al. Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis. Calcif Tissue Int 2012; 91: 286-296.
Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R et al. Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone 2007; 40: 345-353.
Oei L, Zillikens MC, Dehghan A, Buitendijk GH, Castano-Betancourt MC, Estrada K et al. High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care 2013; 36: 1619-1628.
Schneider AL, Williams EK, Brancati FL, Blecker S, Coresh J, Selvin E. Diabetes and risk of fracture-related hospitalization: the Atherosclerosis Risk in Communities Study. Diabetes Care 2013; 36: 1153-1158.
Li CI, Liu CS, Lin WY, Meng NH, Chen CC, Yang SY et al. Glycated hemoglobin level and risk of hip fracture in older people with type 2 diabetes: a competing risk analysis of Taiwan diabetes cohort study. J Bone Miner Res 2015; 30: 1338-1346.
Conway BN, Long DM, Figaro MK, May ME. Glycemic control and fracture risk in elderly patients with diabetes. Diabetes Res Clin Pract 2016; 115: 47-53.
Schwartz AV, Margolis KL, Sellmeyer DE, Vittinghoff E, Ambrosius WT, Bonds DE et al. Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial. Diabetes Care 2012; 35: 1525-1531.
Puar TH, Khoo JJ, Cho LW, Xu Y, Chen YT, Chuo AM et al. Association between glycemic control and hip fracture. J Am Geriatr Soc 2012; 60: 1493-1497.
Johnston SS, Conner C, Aagren M, Ruiz K, Bouchard J. Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes. Diabetes Obes Metab 2012; 14: 634-643.
Hung YC, Lin CC, Chen HJ, Chang MP, Huang KC, Chen YH et al. Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study. Osteoporos Int 2017; 28: 2053-2060.
Ntouva A, Toulis KA, Keerthy D, Adderley NJ, Hanif W, Thayakaran R et al. Hypoglycaemia is associated with increased risk of fractures in patients with type 2 diabetes mellitus: a cohort study. Eur J Endocrinol 2019; 180: 51-58.
Komorita Y, Iwase M, Fujii H, Ohkuma T, Ide H, Jodai-Kitamura T et al. Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetologia 2017; 60: 1922-1930.
Komorita Y, Iwase M, Fujii H, Ohkuma T, Ide H, Jodai-Kitamura T et al. Impact of body weight loss from maximum weight on fragility bone fractures in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetes Care 2018; 41: 1061-1067.
Komorita Y, Iwase M, Fujii H, Ide H, Ohkuma T, Jodai-Kitamura T et al. The serum creatinine to cystatin C ratio predicts bone fracture in patients with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetes Res Clin Pract 2018; 146: 202-210.
Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32: S498-S504.
American Diabetes Association Workgroup of Hypoglycemia. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28: 1245-1249.
Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S, Collaborators Developing the Japanese Equation for Estimated GFR. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis 2013; 61: 197-203.
Bouillanne O, Morineau G, Dupont C, Coulombel I, Vincent JP, Nicolis I et al. Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 2005; 82: 777-783.
Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15: 721-739.
Compston JE, Flahive J, Hosmer DW, Watts NB, Siris ES, Silverman S et al. Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). J Bone Miner Res 2014; 29: 487-493.
Thayakaran R, Perrins M, Gokhale KM, Kumaran S, Narendran P, Price MJ et al. Impact of glycaemic control on fracture risk in 5368 people with newly diagnosed Type 1 diabetes: a time-dependent analysis. Diabet Med 2019; 36: 1013-1019.
Kojima G. Frailty as a predictor of fractures among community-dwelling older people: A systematic review and meta-analysis. Bone 2016; 90: 116-122.
Diaz de Bustamante M, Alarcon T, Menendez-Colino R, Ramirez-Martin R, Otero A, Gonzalez-Montalvo JI. Prevalence of malnutrition in a cohort of 509 patients with acute hip fracture: the importance of a comprehensive assessment. Eur J Clin Nutr 2018; 72: 77-81.
Saito M, Fujii K, Mori Y, Marumo K. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int 2006; 17: 1514-1523.
Cukierman-Yaffe T, Bosch J, Jung H, Punthakee Z, Gerstein HC. Hypoglycemia and incident cognitive dysfunction: a post hoc analysis from the ORIGIN Trial. Diabetes Care 2019; 42: 142-147.
Lorenzo-Lopez L, Maseda A, de Labra C, Regueiro-Folgueira L, Rodriguez-Villamil JL, Millan-Calenti JC. Nutritional determinants of frailty in older adults: a systematic review. BMC Geriatr 2017; 17: 108.
Jackson RD, Mysiw WJ. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative. Semin Reprod Med 2014; 32: 454-462.
Ettinger B, Black DM, Nevitt MC, Rundle AC, Cauley JA, Cummings SR et al. Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1992; 7: 449-456.
American Diabetes Association. Standards of Medical Care in Diabetes-2019. Diabetes Care 2019; 42: S1-S193.

Auteurs

Y Komorita (Y)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Division of Internal Medicine, Fukuoka Dental College, Fukuoka, Japan.

M Iwase (M)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Diabetes Centre, Hakujyuji Hospital, Fukuoka, Japan.

H Fujii (H)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

T Ohkuma (T)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

H Ide (H)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Division of General Internal Medicine, School of Oral Health Science, Kyushu Dental University, Kitakyushu, Japan.

M Yoshinari (M)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Y Oku (Y)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

U Nakamura (U)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

T Kitazono (T)

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH